These results suggest that the elevated IL-6 associated with TP53-mutant tumors may be derived from the tumor cells as well as from macrophages and other cells of the microenvironment and that TP53-mutant GC tumor cells develop an IL-6 dependency to serve their requirement for continuous STAT3 signaling. The gene discussed is TP53; the disease is neoplasm.